Big data, machine learning and drug discovery in oncology

Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells

Using circulating tumour DNA dynamics to predict outcomes in advanced cancers

Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma

Prospective validation of single mouse testing by the paediatric preclinical testing consortium

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

The ENA virtual meeting 2020

Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation

Development of novel inhibitors of KRASG12C

Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy